Reactive metabolite activation by CYP2C19-mediated rhein hepatotoxicity

References

• Adam D. (2011). Drug-induced liver injury. Medicine 39:536–40
   Google Scholar
• Amacher DE. (2012). The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury. Expert Opin Drug Metab Toxicol 8:335–47
   PubMed Web of Science ®Google Scholar
• Bertelsen KM, Venkatakrishnan K, Von Moltke LL, et al. (2003). Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine. Drug Metab Dispos 31:289–93
   PubMed Web of Science ®Google Scholar
• Bironaite D, Ollinger K. (1997). The hepatotoxicity of rhein involves impairment of mitochondrial functions. Chem Biol Interact 103:35–50
   PubMed Web of Science ®Google Scholar
• Björnsson E. (2010). Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther 32:3–13
   PubMed Web of Science ®Google Scholar
• Dinger J, Meyer MR, Maurer HH. (2014). Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicol Lett 230:28–35
   PubMed Web of Science ®Google Scholar
• Du Q, Bian XL, Xu XL, et al. (2013). Role of mitochondrial permeability transition in human hepatocellular carcinoma Hep-G2 cell death induced by rhein. Fitoterapia 91:68–73
   PubMed Web of Science ®Google Scholar
• Fontana E, Dansette PM, Poli SM. (2005). Cytochrome P450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Curr Drug Metab 6:413–54
   PubMed Web of Science ®Google Scholar
• Goldstein JA. (2001). Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol 52:349–55
   PubMed Web of Science ®Google Scholar
• Grimm SW, Einolf HJ, Hall SD, et al. (2009). The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos 37:1355–70
   PubMed Web of Science ®Google Scholar
• Kalgutkar AS, Didiuk MT. (2009). Structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity. Chem Biodivers 6:2115–37
   PubMed Web of Science ®Google Scholar
• Kay AGL, Griffiths LF, Volans GN, et al. (1980). Preliminary experience with diacethyl-rhein in the treatment of osteoarthritis. Curr Med Res 6:548–51
   PubMed Web of Science ®Google Scholar
• Lai WW, Yang JS, Lai KC, et al. (2009). Rhein induced apoptosis through the endoplasmic reticulum stress, caspase-and mitochondria-dependentpathways in SCC-4 human tongue squamous cancer cells. In Vivo 23:309–16
   PubMed Web of Science ®Google Scholar
• Lammert C, Bjornsson E, Niklasson A, et al. (2010). Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 51:615–20
   PubMed Web of Science ®Google Scholar
• Lin S, Fujii M, Hou DX. (2003). Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway. Arch Biochem Biophys 418:99–107
   PubMed Web of Science ®Google Scholar
• Malterud KE, Farbrot TL, Huse AE, et al. (1993). Antioxidant and radical scavenging effects of anthraquinones and anthrones. Pharmacology 47:77–85
   PubMed Web of Science ®Google Scholar
• McConn DJ, Zhao Z. (2004). Integrating in vitro kinetic data from compounds exhibiting induction, reversible inhibition and mechanism-based inactivation: in vitro study design. Curr Drug Metab 5:141–6
   PubMedGoogle Scholar
• Nakayama S, Takakusa H, Watanabe A, et al. (2011). Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites. Drug Metab Dispos 39:1247–54
   PubMed Web of Science ®Google Scholar
• Obach RS, Walsky RL, Venkatakrishnan K. (2007). Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug–drug interactions. Drug Metab Dispos 35:246–55
   PubMed Web of Science ®Google Scholar
• Peterson LA, Cummings ME, Vu CC, et al. (2005). Glutathione trapping to measure microsomal oxidation of furan to cis-2-butene-1,4-dial. Drug Metab Dispos 33:1453–8
   PubMed Web of Science ®Google Scholar
• Roehm NW, Rodgers GH, Hatfield SM, et al. (1991). An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142:257–65
   PubMed Web of Science ®Google Scholar
• Schmidt J, Kotnik P, Trontelj J, et al. (2013). Bioactivation of bisphenol A and its analogs (BPF, BPAF, BPZ and DMBPA) in human liver microsomes. Toxicol In Vitro 27:1267–76
   PubMedGoogle Scholar
• Sean XP, Arminda GB, David MR. (2003). High-throughput cytochrome P450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns. Rapid Commun Mass Spectrum 17:509–18
   PubMedGoogle Scholar
• Seglen PO. (1972). Preparation of rat liver cells. I. Effect of Ca2+ on enzymatic dispersion of isolated, perfused liver. Exp Cell Res 74:450–4
   PubMed Web of Science ®Google Scholar
• Shimada T, Fujii-Kuriyama Y. (2004). Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci 95:1–6
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, et al. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–23
   PubMed Web of Science ®Google Scholar
• Silverman RB. (1988). Mechanism-based enzyme inactivation: chemistry and enzymology. Boca Raton (FL): CRC Press
   Google Scholar
• Song R, Xu F, Zhang Z, et al. (2008). Structural elucidation of in vitro metabolites of emodin by liquid chromatography—tandem mass spectrometry. Biomed Chromatogr 22:1230–6
   PubMed Web of Science ®Google Scholar
• Takahashi N, Subehan, Kadota S, Tezuka Y. (2012). Mechanism-based CYP2D6 inactivation by acridone alkaloids of Indonesian medicinal plant Lunasia amara. Fitoterapia 83:774–9
   PubMedGoogle Scholar
• Tang JC, Yang H, Song XY, et al. (2009). Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes. Phytother Res 23:159–64
   PubMed Web of Science ®Google Scholar
• Wang CJ, Hu CP, Xu KP, et al. (2010). Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells. Naunyn Schmiedebergs Arch Pharmacol 381:73–81
   PubMed Web of Science ®Google Scholar
• Xie C, Zhong D, Chen X. (2013). A fragmentation-based method for the differentiation of glutathione conjugates by high-resolution mass spectrometry with electrospray ionization. Anal Chim Acta 788:89–98
   PubMed Web of Science ®Google Scholar
• Zhao YL, Zhou GD, Yang HB, et al. (2011). Rhein protects against acetaminophen-induced hepatic and renal toxicity. Food Chem Toxicol 49:1705–10
   PubMed Web of Science ®Google Scholar
• Zhong XF, Huang GD, Luo T, et al. (2012). Protective effect of rhein against oxidative stress-related endothelial cell injury. Mol Med Rep 5:1261–6
   PubMed Web of Science ®Google Scholar